Dr. Susan K. Buchanan, Ph.D. is a research scientist in the intramural program, running her own research group of about 8 people. In addition, she is the Chief of Molecular Biology, where she oversees 9 other research groups as one of only two women Lab/Branch Chiefs in in the National Institute for Diabetes & Digestive & Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). She was recently promoted to Deputy Scientific Director at NIDDK.
Meet Dr. Rita Devine, the Assistant Director, for Science Administration at National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH). The Office of Equity, Diversity, and Inclusion (EDI) recognizes Dr. Devine because of her commitment to diversity and inclusion at the NIH. Dr. Devine’s support for NIH’s diversity and inclusion initiatives has resulted in numerous internships and life-changing opportunities for many underrepresented groups. She has overseen the participation of Native Americans (NA) in the NIH summer internship program for the past eleven years in addition to many other contributions she makes each day to the NIH. Dr.
My name is David Rice, I work for NIH and I Am HHS. For me, being deaf has been a blessing -- and it has made me who I am today.
I am pleased to nominate Dr. Ofelia A. Olivero as an NIH Game Changer, in recognition for her leadership and commitment to furthering NIH’s equity diversity and inclusion efforts. Dr. Olivero is widely respected for her support of equal opportunities and for conveying the importance of mentoring across cultural and gender backgrounds. Dr. Olivero’s support to NIH’s diversity and inclusion (D&I) has resulted in numerous training fellows gaining access to NIH programs, most of them from underrepresented groups. A list of more than 35 program participants, all directly hired and mentored by her is a remarkable accomplishment. Most of her students are now either Ph.D. and/or M.D.
Nine days after the monstrous 2016 blizzard nicknamed Snowzilla, the sun shone in a bright blue sky on a balmy 50-degree day at the main NIH campus in Bethesda, Maryland—the perfect setting for a four-mile run with two men who’ve logged nearly a thousand miles together.
This month, we sat down with the newly established Sexual and Gender Minority Research Office at the National Institutes of Health to learn more about their operations and the future of SGM biomedical research.
SGM is an acronym meaning 'Sexual and Gender Minority.' It is an umbrella term that encompasses lesbian, gay, bisexual, and transgender populations as well as those whose sexual orientation, gender identity and expressions, or reproductive development varies from traditional, societal, cultural, or physiological norms.
Phil Lenowitz, former Deputy Director of the NIH Office of Human Resources (OHR), is a recipient of the 2013 NIH Office of the Director Merit Award for his remarkable work and noteworthy efforts in pioneering the first-ever NIH Veterans Day Celebration in 2012. The NIH Office of Equity, Diversity, and Inclusion has selected Phil as our (Month Year) Game Changer because of his firm commitment in diversity and inclusion, and his deeply rooted understanding that our veterans are a critical piece of our overall diversity strategy. He has proudly made our veterans a priority for the NIH.